000623.SZ · 吉林敖东
China A-shares · RS rating 68 · As of 2026-10-14
| Price | 17.45 CNY |
|---|---|
| 1-day change | +0.3% |
| RS rating (overall / 1M / 3M / 12M) | 68 / 59 / 46 / 61 |
| Stage | Basing |
| Composite / Minervini / CANSLIM score | 25 / 33 / 15 |
| Industry group (rank) | Medical-Generic Drugs (40) |
| EPS growth Q/Q | – |
| Sales growth Q/Q | +0.6% |
| Distance from 52-week high | +20.0% |
| Market cap (USD) | $3.1B |